| New from NCI |
| Fertility Preservation for Young Male Cancer Survivors |
 | | A study in monkeys has shown promise in preserving the fertility of young boys being treated for cancer. |
| Immunotherapy Drug Shows Promise against HPV-Related Cancers |
 | | In a phase 1 clinical trial, an experimental immunotherapy drug shrank the tumors of some patients with advanced human papillomavirus (HPV)-related cancers. |
Telephone-Based Rehab for People with Advanced Cancer
Learn about a study that found that a physical rehabilitation program delivered by telephone helped improve function and reduce pain for people with advanced cancer. |
Genetic Testing for Inherited Cancer Susceptibility Syndromes
This page has been recently updated. Learn about genetic testing, which tests are available, and who should think about genetic testing for cancer risk. |
| Video—A Dialogue on Cancer Disparities, Prevention, and Research |
 | | If you missed the live broadcast, you can now watch the recording of our Facebook Live event. Listen as subject matter experts discuss cancer disparities and the work being done to help reduce them. |
| PDQ Cancer Information Summary Updates |
Childhood Liver Cancer Treatment
We’ve revised our childhood liver cancer summary to include radiofrequency ablation as a standard treatment option for progressive or recurrent hepatoblastoma. |
Melanoma Treatment
We’ve revised our melanoma summary with updated information on targeted therapy used to treat this disease. |
| Drug Information Updates |
New Drug for Bladder Cancer
We’ve added a new drug information summary for erdafitinib (Balversa). It was recently approved by the Food and Drug Administration to treat locally advanced or metastaticbladder cancer with certain changes involving the FGFR3 or FGFR2 gene. Erdafitinib is used in adults whose disease worsened during or after treatment with other chemotherapy. |
No hay comentarios:
Publicar un comentario